Sergey Sikora, Ph.D., MBA
President and CEO,CardioCell LLC
Dr. Sergey Sikora has eight years of management and 12 years of biomedical-research experience. He brought his expertise in cardiology diagnostics and therapeutics to CardioCell’s parent company Stemedica in 2013. Before that, Dr. Sikora served as SVP at GenWay, where he established and led the FirstMark Cardiology Diagnostics Division and successfully divested two of the largest divisions of GenWay to Sigma-Aldrich. His career also includes founder and VP of Business Development at MC-Fibers. Dr. Sikora earned his Ph.D. from UCLA, MBA from the Rady School of Management at UC San Diego and B. S. in biochemistry cum laude from UCLA. He currently chairs FirstMark’s Scientific Advisory Board, which comprises top U.S. opinion leaders in cardiology.